(Q28379243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

0 references

1 reference

Romand S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Della Bruna C

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Farinotti R

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Derouin F

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 September 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

2015-2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

Rifabutin is active in murine models of toxoplasmosis

20 October 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

Enzyme immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue culture

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

Pharmacokinetics of rifabutin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

Malaria and other Apicomplexans: the "plant" connection.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163465

In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8878573

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High-performance liquid chromatographic assay for the measurement of atovaquone in plasma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8878573

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.40.9.2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8878573%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

PubMed publication ID

8878573

1 reference